The use of attention-deficit hyperactivity disorder medications in cardiac disease.

Topriceanu, Constantin-Cristian; Moon, James C; Captur, Gabriella; Perera, Bhathika

Topriceanu, Constantin-Cristian; Moon, James C; Captur, Gabriella; Perera, Bhathika.

Afiliação

Topriceanu CC; Barnet, Enfield and Haringey Mental Health Trust, London, United Kingdom.
Moon JC; UCL Institute of Cardiovascular Science, University College London, London, United Kingdom.
Captur G; UCL MRC Unit for Lifelong Health and Ageing, University College London, London, United Kingdom.
Perera B; Cardiac MRI Unit, Barts Heart Centre, London, United Kingdom.

Front Neurosci ; 16: 1020961, 2022.

Article em En | MEDLINE | ID: mdl-36340760

Palavras-chave

ADHD (attention deficit and hyperactivity disorder); aortopathies; blood pressure; cardiomyopathies; cardiovascular disease; electrocardiogram (ECG); non-stimulant medications for ADHD; stimulant medications for ADHD

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Front Neurosci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google